ArticleBMJ public health2025

Global disparities in access to hepatitis C medicines before and during the early phase of the COVID-19 pandemic: an ARIMA-based interrupted time series analysis.

Marie Paul Nisingizwe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.